Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer version of the page. This appears to be a minor maintenance update rather than a substantive change to the study details.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new revision tag appears on the page: Revision: v3.5.4, indicating the page has been updated to the latest revision. The previous revision label (v3.5.3) is removed.SummaryDifference0.0%

- Check40 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3, reflecting a minor metadata update to the page. This change does not modify study details, eligibility criteria, or results.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision updated to v3.5.0; the v3.4.3 entry has been removed.SummaryDifference0.0%

- Check90 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.